2.1(top 8%)
Impact Factor
2.3(top 8%)
extended IF
24(top 15%)
H-Index
567
authors
484
papers
3.1K
citations
564
citing journals
2.1K
citing authors

Most Cited Articles of Pharmacogenomics and Personalized Medicine

TitleYearCitations
Human ABC transporter ABCG2/BCRP expression in chemoresistance: basic and clinical perspectives for molecular cancer therapeutics201484
 Pharmacogenomic considerations in opioid analgesia. [Corrigendum]201378
Association of the 5-HTT gene-linked promoter region (5-HTTLPR) polymorphism with psychiatric disorders: review of psychopathology and pharmacotherapy201275
Pharmacogenomic knowledge gaps and educational resource needs among physicians in selected specialties201471
Clinical potential of novel therapeutic targets in breast cancer: CDK4/6, Src, JAK/STAT, PARP, HDAC, and PI3K/AKT/mTOR pathways201469
H3Africa: current perspectives201858
Immunologic checkpoints in cancer therapy: focus on the programmed death-1 (PD-1) receptor pathway201449
Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics201648
ABCG2 polymorphisms in gout: insights into disease susceptibility and treatment approaches201747
Emerging biomarkers in the diagnosis of prostate cancer201847
Implementation and utilization of genetic testing in personalized medicine201444
Glioblastoma extracellular vesicles: reservoirs of potential biomarkers201443
The current and future state of companion diagnostics201539
Pharmacogenomics of statins: understanding susceptibility to adverse effects201638
UGT1A1 polymorphisms in cancer: impact on irinotecan treatment201731
DNA methylation at the mu-1 opioid receptor gene () promoter predicts preoperative, acute, and chronic postsurgical pain after spine fusion201729
Update on the clinical utility of an RNA interference-based treatment: focus on Patisiran201729
Inconsistency in race and ethnic classification in pharmacogenetics studies and its potential clinical implications201929
Role of pharmacogenomics in the treatment of tuberculosis: a review201229
ABCB1 haplotype and OPRM1 118A > G genotype interaction in methadone maintenance treatment pharmacogenetics201229
Olaparib in the management of ovarian cancer201527
The utility of pharmacogenetic testing to support the treatment of bipolar disorder201825
Delivering pharmacogenetic testing in a primary care setting201325
Pharmacogenomics of drug metabolizing enzymes and transporters: implications for cancer therapy201125
Personalized medicine in breast cancer: pharmacogenomics approaches201924